Korro Bio (NASDAQ:KRRO – Get Free Report) and BeOne Medicines (NASDAQ:ONC – Get Free Report) are both healthcare companies, but which is the superior investment? Get Korro Bio alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Korro Bio $6.39 million 28.65 -$117.26 million ($11.67) -1.09 BeOne Medicines $5.34 billion 7.11 $286.93 million $4.47 77.48Insider & Institutional OwnershipBeOne Medicines has higher revenue and earnings than Korro Bio. Given Korro Bio’s stronger consensus rating and higher possible upside, equities analysts plainly believe Korro Bio is more favorable than BeOne Medicines. ProfitabilityThis table compares Korro Bio and BeOne Medicines’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Korro Bio -1,834.48% -117.86% -71.04% BeOne Medicines 10.70% 14.85% 8.07%SummaryBeOne Medicines beats Korro Bio on 10 of the 15 factors compared between the two stocks.